Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)
- 31 March 2006
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 44 (3) , 484-490
- https://doi.org/10.1016/j.jhep.2005.11.038
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Amantadine in treatment of chronic hepatitis C virus infection?Journal of Viral Hepatitis, 2005
- Evaluation of amantadine in chronic hepatitis C: a meta-analysisJournal of Hepatology, 2004
- Combination therapy with amantadine and interferon in naı̈ve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trialsJournal of Hepatology, 2004
- Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis CJournal of Hepatology, 2003
- Peginterferon vs. standard interferon in the treatment of chronic hepatitis CAlimentary Pharmacology & Therapeutics, 2003
- Treatment options for nonresponders and relapsers to initial therapy for hepatitis C.Cleveland Clinic Journal of Medicine, 2003
- The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, AmantadineFEBS Letters, 2002
- Interferon plus amantadine versus interferon alone in the treatment of naı̈ve patients with chronic hepatitis C: a UK multicentre studyJournal of Hepatology, 2001
- Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?Journal of Hepatology, 2001
- Clinical Pharmacokinetics of Amantadine HydrochlorideClinical Pharmacokinetics, 1988